MONICA FAWCETT: Open Payments
NPI 1740043728 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 33 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $136 · 2025 $855
Food & beverage: $766Education: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $181 |
| GENZYME CORPORATION | 1 | $118 |
| Actelion Pharmaceuticals US, Inc. | 2 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98 |
| Grifols USA, LLC | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Amgen Inc. | 2 | $32 |
| Insmed, Inc. | 1 | $30 |
| Electromed, Inc. | 2 | $27 |
Products named: DUPIXENT, FASENRA, OPSUMIT, Prolastin-C Liquid, OFEV, TEZSPIRE, GLASSIA, JASCAYD.
Industry payments across MO — which companies pay providers there.
